Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Enzo Biochem's Pre-Tax Income for the
three
months ended in Jan. 2024 was $-0.86 Mil. Enzo Biochem's Revenue for the
three
months ended in Jan. 2024 was $8.55 Mil. Therefore, Enzo Biochem's pretax margin for the quarter that ended in Jan. 2024 was -10.09%.
The historical rank and industry rank for Enzo Biochem's Pretax Margin % or its related term are showing as below:
ENZ'
s Pretax Margin % Range Over the Past 10 Years
Min: -80.56 Med: -6.35 Max: 45.11
Current: -75
ENZ's Pretax Margin % is ranked worse than 69.47% of 226
companies
in the Medical Diagnostics & Research industry
Industry Median: -11.2
vs ENZ: -75.00
Enzo Biochem Pretax Margin % Historical Data
The historical data trend for Enzo Biochem's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Enzo Biochem's Pretax Margin %
For the Diagnostics & Research subindustry, Enzo Biochem's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Enzo Biochem's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Enzo Biochem's Pretax Margin % falls into.
Enzo Biochem Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Enzo Biochem's Pretax Margin for the fiscal year that ended in Jul. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Enzo Biochem Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Enzo Biochem's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENZ has been successfully added to your 